Atlas Trials

Pegylated Irinotecan NKTR 102 in Treating Patients With Relapsed Small Cell Lung Cancer

Clinical trial NCT01876446 · COMPLETED

Trial details

NCT number
NCT01876446
Sponsor
Roswell Park Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Small Cell Lung Carcinoma
Start date
2013-08-29
Primary completion
2017-07-18
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.